共 15 条
[1]
Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. Rubin SA,Pletnikov M,Carbone KM. Journal of Virology . 1998
[2]
Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Broliden K,Abreu ER,Arneborn M,et al. Vaccine . 1998
[3]
Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. Amexis G,Rubin S,Chatterjee N,et al. Journal of Medical Virology . 2003
[4]
Persistence of anti -mumps virus antibodies after as two-dose MMR vaccination.A nineyear follow-up. Davidkin I,Valle M,Julkunen I. Vaccine . 1995
[5]
Mumps virus neutrali zing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Nojd J,Tecle T,Samuelsson A,et al. Vaccine . 2001
[6]
Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. Rubin SA,Pletnikov M,Taffs R,et al. Journal of Virology .
[7]
Immunogenicity of second dose measles-mumps-rubella ( MMR ) vaccine and implication for serosurveillance. Pebody RG,Gay NJ,Hesketh LM,et al. Vaccine . 2002
[8]
Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. Orvell C,Tecle T,Johansson B,et al. Journal of General Virology . 2002
[9]
Outbreak of mumps in a vaccinated child population: a question of vaccine failure. Vandermeulen C,Roelants M,Vermoere M,et al. Vaccine . 2004
[10]
WHO position paper. Mumps virus vaccines. Wkly Epidem Rec . 2001